Stop Sepsis

Empowering healthcare providers to suspect, treat and prevent sepsis in women and newborns.

The Global Maternal Sepsis Study

Global Maternal Sepsis Study (GLOSS), helped quantify the burden and assess the current management of maternal and neonatal sepsis. The study looked at how women with infection during pregnancy, childbirth, postpartum, or post-abortion are identified and treated in participating health facilities.

Over the course of one week between 28 November and 04 December 2017, the study prompted a massive coordinated data collection effort in over 700 healthcare facilities in 52 countries across the world. By clicking on the participating countries below, you will see the names of all the people involved with the study at the country level. The new and potential identification criteria were also tested and validated in this large global study.

The main results of the GLOSS study showed that around 70 pregnant or recently-pregnant women per 1000 live births develop maternal infections needing hospital management. Across the study, 11 women with either direct or indirect infection per 1000 live births developed a severe maternal outcome, but in low- and middle-income countries up to 15 women per 1000 births were affected. In addition, GLOSS results suggest that current levels of monitoring and clinical care across health facilities are not enough to prevent, identify and treat levels of maternal infection effectively.

Go to more GLOSS publications    

Disclaimer: The boundaries and names shown and the designations used on this map do not imply official endorsement or acceptance by the World Health Organization or the Global Maternal Sepsis Study researchers.

The project has been funded by: